doi.org/10.1016/s0016-5085(20)34283-9

Tu1670 USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN POPULATIONS WITH NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE

,

Jeremy Broestl,

..., Nezam H. Afdhal

Gastroenterology29.40

Volume: 158, Issue: 6, Pages: S - 1446

Published: May 1, 2020

Abstract

No abstract.

Paper Fields

Paper Details

Title

Tu1670 USE OF GLP-1 RECEPTOR AGONISTS (GLP1A) AND/OR SGLT-2 INHIBITORS (SGLT2I) IN POPULATIONS WITH NASH OR AT RISK OF NASH IN US CLINICAL PRACTICE

DOI

doi.org/10.1016/s0016-5085(20)34283-9

Published Date

May 1, 2020

Journal

Gastroenterology

Volume

158

Issue

6

Pages

S - 1446

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Notes

History